메뉴 건너뛰기




Volumn 46, Issue 4, 2007, Pages 416-419

High-dose chemotherapy and hematopoietic stem cell transplantation in patients with germ cell cancer;Hochdosischemotherapie und hämatopoetische stammzelltransplantation bei patienten mit keimzelltumoren

Author keywords

Germ cell cancer; Hematopoietic stem cell transplantation; High dose chemotherapy; Primary treatment; Salvage therapy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; VINBLASTINE;

EID: 34247203060     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1318-5     Document Type: Review
Times cited : (1)

References (11)
  • 1
    • 34247234957 scopus 로고    scopus 로고
    • Bajorin DF, Nichols CR, Margolin KW et al. (2006) Phase III trial of conventional-dose chemotherapy alone or with high-dose chemotherapy for metastic germ cell tumors (GCT) patients (PTS): A cooperative group trial by Memorial Sloan-Kettering Cancer Center, ECOG, SWOG, and CALGB. ASCO #4510
    • Bajorin DF, Nichols CR, Margolin KW et al. (2006) Phase III trial of conventional-dose chemotherapy alone or with high-dose chemotherapy for metastic germ cell tumors (GCT) patients (PTS): A cooperative group trial by Memorial Sloan-Kettering Cancer Center, ECOG, SWOG, and CALGB. ASCO #4510
  • 2
    • 12144279216 scopus 로고    scopus 로고
    • Chemotherapie von Keimzelltumoren
    • Beyer J, Bokemeyer C (2004) Chemotherapie von Keimzelltumoren. Urologe A 43: 1507-1513
    • (2004) Urologe A , vol.43 , pp. 1507-1513
    • Beyer, J.1    Bokemeyer, C.2
  • 3
    • 0031037241 scopus 로고    scopus 로고
    • The International Germ Cell Consensus Classification: A prognostic factor based staging system for metastastic germ cell cancer
    • International Germ Cell Cancer Collaborative Group IGCCCG
    • International Germ Cell Cancer Collaborative Group (IGCCCG) (1997) The International Germ Cell Consensus Classification: a prognostic factor based staging system for metastastic germ cell cancer. J Clin Oncol 15: 594-603
    • (1997) J Clin Oncol , vol.15 , pp. 594-603
  • 4
    • 0344734200 scopus 로고    scopus 로고
    • Vinblastine plus Ifosfamide plus Cisplatin as initial salvage therapy in recurrent germ cell tumor
    • Loehrer PJ, Gonin R, Nichols CR et al. (1998) Vinblastine plus Ifosfamide plus Cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16: 2500-2504
    • (1998) J Clin Oncol , vol.16 , pp. 2500-2504
    • Loehrer, P.J.1    Gonin, R.2    Nichols, C.R.3
  • 5
    • 34247251234 scopus 로고    scopus 로고
    • Lorch A, Rick O, Hartmann JT et al. (2006) Single versus sequential high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ-cell tumors (GCT). ASCO #4511
    • Lorch A, Rick O, Hartmann JT et al. (2006) Single versus sequential high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ-cell tumors (GCT). ASCO #4511
  • 6
    • 0034018301 scopus 로고    scopus 로고
    • Sequential dose-intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage therapy for germ cell tumor patients
    • Motzer RJ, Mazumdar M, Sheinfeld Joel et al. (2000) Sequential dose-intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage therapy for germ cell tumor patients. J Clin Oncol 18: 1173-1180
    • (2000) J Clin Oncol , vol.18 , pp. 1173-1180
    • Motzer, R.J.1    Mazumdar, M.2    Joel, S.3
  • 7
    • 33750091954 scopus 로고    scopus 로고
    • Entwicklungen in der hämatopoetischen Stammzelltransplantation
    • Ottinger H, Müller C, Beelen DW et al. (2006) Entwicklungen in der hämatopoetischen Stammzelltransplantation. Dtsch Ärztebl A 103: 2381-2386
    • (2006) Dtsch Ärztebl A , vol.103 , pp. 2381-2386
    • Ottinger, H.1    Müller, C.2    Beelen, D.W.3
  • 8
    • 25144455744 scopus 로고    scopus 로고
    • A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors
    • Pico JL, Rosti G, Kramar A et al. (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors. Ann Oncol 16: 1152-1159
    • (2005) Ann Oncol , vol.16 , pp. 1152-1159
    • Pico, J.L.1    Rosti, G.2    Kramar, A.3
  • 9
    • 0642347620 scopus 로고    scopus 로고
    • Long-term results of first-line sequential high-dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy plus autologous Stemm cell support for patients with advanced metastatic germ cell cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group
    • Schmoll H-J, Kollmannsberger C, Metzner B et al. (2003) Long-term results of first-line sequential high-dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy plus autologous Stemm cell support for patients with advanced metastatic germ cell cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group. J Clin Oncol 21: 4083-4091
    • (2003) J Clin Oncol , vol.21 , pp. 4083-4091
    • Schmoll, H.-J.1    Kollmannsberger, C.2    Metzner, B.3
  • 10
    • 4644330119 scopus 로고    scopus 로고
    • European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG)
    • Schmoll HJ, Souchon R, Krege S et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15: 1377-1399
    • (2004) Ann Oncol , vol.15 , pp. 1377-1399
    • Schmoll, H.J.1    Souchon, R.2    Krege, S.3
  • 11
    • 0642378134 scopus 로고    scopus 로고
    • Longterm survival after high-dose salvage chemotherapy for germ gell malignancies with adverse prognostic variables
    • Vaena DA, Abonour R, Einhorn LH (2003) Longterm survival after high-dose salvage chemotherapy for germ gell malignancies with adverse prognostic variables. J Clin Oncol 21:4100-4104
    • (2003) J Clin Oncol , vol.21 , pp. 4100-4104
    • Vaena, D.A.1    Abonour, R.2    Einhorn, L.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.